DexCom
DXCM
983 hedge funds and large institutions have $26.1B invested in DexCom in 2026 Q2 according to their latest regulatory filings, with 127 funds opening new positions, 402 increasing their positions, 350 reducing their positions, and 103 closing their positions.
57% more capital inflows, than outflows
Capital inflows: $3.52B | Capital outflows: $2.24B
23% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 103
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
15% more repeat investments, than reductions
Existing positions increased: 402 | Existing positions reduced: 350
3.92% more ownership
Funds ownership: 96.64% → 100.56% (+3.9%)
1% more funds holding
Funds holding: 969 → 983 (+14)
5% less call options, than puts
Call options by funds: $334M | Put options by funds: $351M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$288M |
| 2 |
Castle Hook Partners
New York
|
+$204M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$140M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$114M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$108M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$178M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$86.9M |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$86.2M |
| 4 |
SG Americas Securities
New York
|
-$83M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$82M |
DXCM Hedge Fund Activity: Q2 2026 in Review
983 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2026, worth a combined $26.1B — up 12% from $23.4B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new DXCM positions and 103 closed out — a net gain of 24 holders — while 402 added to existing stakes and 350 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $288M. The largest seller was JP Morgan Chase, cutting an estimated $178M.
- 983 institutional investors held DexCom (DXCM) as of Q2 2026, up from 969 in Q1 2026.
- Funds reported $26.1B of DexCom stock for Q2 2026, up 12% quarter-over-quarter.
- 127 funds opened new DexCom positions in Q2 2026 and 103 closed out, a net change of +24 holders.
- The largest DexCom buyer in Q2 2026 was Arrowstreet Capital, an estimated $288M added.
- The largest DexCom seller in Q2 2026 was JP Morgan Chase, an estimated $178M sold.
Based on aggregated 13F filings for Q2 2026.